Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00068731 · ClinicalTrials.gov registry record · Phase 2
Lycopene in Treating Patients With Metastatic Prostate Cancer
A Phase 2 study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- Phase 2
- Development phase
- 47
- Enrollment target
NCT00068731 is a Phase 2 study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 47 participants.
The verdict
NCT00068731, a Phase 2 study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 47 participants
- Enrollment target
Study Summary
RATIONALE: Lycopene, a substance found in tomatoes, may lower prostate-specific antigen (PSA) levels and slow or prevent the development of prostate cancer. PURPOSE: Phase II trial to study the effectiveness of lycopene in treating patients who have asymptomatic metastatic prostate cancer and a rising PSA level.
Interventions
- DIETARY_SUPPLEMENT lycopene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2004-01 |
| Est. Completion | 2009-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00068731
The ClinicalTrials.gov registry entry for NCT00068731 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lycopene is the first listed.
NCT00068731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00068731 about?
NCT00068731 is a clinical study titled "Lycopene in Treating Patients With Metastatic Prostate Cancer". RATIONALE: Lycopene, a substance found in tomatoes, may lower prostate-specific antigen (PSA) levels and slow or prevent the development of prostate cancer. PURPOSE: Phase II trial to study the effectiveness of lycopene in treating patients who have asymptomatic metastatic prostate cancer and a ris...
What is the current status of trial NCT00068731?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 47 participants. The study started on 2004-01. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00068731?
The interventions under investigation include: lycopene (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00068731?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.